ILMN Stock Recent News Illumina Inc (ILMN) 186.35 11/09/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Illumina Inc (ILMN) 186.35 $ILMN

A/D Rating Helps Spot What The Pros Are Buying
at Investor's Business Daily - Thu Nov 06, 5:41PM CST
If you're prepping a small patch of land, a shovel and a hoe from Home Depot (HD) will suffice. But if you have acres to dig up, then you'll need industrial-size earth-moving equipment. In the stock market, it takes big money from professional...
BCC: 37.43 (-0.17), HD: 97.65 (+0.36), AKRX: 36.59 (-1.29), ILMN: 186.35 (-3.52)

'Mad Money' Lightning Round: Pull the Trigger on Baxter
at The Street - Thu Nov 06, 5:00AM CST
Cramer likes Illumina but isn't a big fan of GEO Group or AK Steel Holdings.
RIG: 29.71 (-0.21), GEO: 41.40 (+0.76), TMO: 116.60 (-2.31), ESV: 41.31 (+0.81), NUE: 54.18 (+0.70), BAX: 70.61 (-0.99), ILMN: 186.35 (-3.52), AKS: 6.62 (+0.48), OXY: 88.04 (+1.64)

Jim Cramer's 'Mad Money' Recap: What a Republican Senate Means for Stocks
at The Street - Wed Nov 05, 7:20PM CST
It's bullish news but you can't buy just anything, Cramer says.
ACT: 245.91 (-4.47), LMT: 186.15 (-3.73), XOM: 96.59 (+0.33), ILMN: 186.35 (-3.52), AKS: 6.62 (+0.48), KORS: 69.95 (-2.36), PAYX: 47.33 (-0.24), RIG: 29.71 (-0.21), EOG: 99.55 (+0.58), COST: 137.71 (+0.62), TWTR: 40.31 (-0.53), OXY: 88.04 (+1.64), KO: 42.32 (+0.03), SEAS: 18.39 (-0.45), TMO: 116.60 (-2.31), NUE: 54.18 (+0.70), TRIP: 73.65 (-0.35), DISCA: 32.62 (-0.28), CHUY: 22.02 (+0.02), LB: 75.61 (-0.74), GEO: 41.40 (+0.76), ESV: 41.31 (+0.81), MPC: 94.08 (+0.95), BAX: 70.61 (-0.99), MRK: 59.34 (+0.08), EXPE: 85.11 (+1.05), STI: 39.66 (-0.16)

SmarTrend Watching for Potential Rebound in Shares of Illumina After 2.63% Loss
Comtex SmarTrend(R) - Wed Nov 05, 4:33PM CST
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $184.83 to a high of $194.13. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $189.64 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 186.35 (-3.52)

Illumina Falls 2.63% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Nov 05, 4:33PM CST
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $184.83 to a high of $194.13. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $189.64 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 186.35 (-3.52)

Top Funds Buy Ulta Beauty, Alexion, Avago
at Investor's Business Daily - Tue Nov 04, 5:52PM CST
Managers of leading mutual funds in recent months have continued to stock up on large medical stocks, such as Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Celgene (CELG), Jazz Pharmaceuticals (JAZZ),Allergan (AGN) and Centene (CNC). The...
AMBA: 47.14 (+1.13), MNST: 108.39 (+7.91), SWKS: 59.88 (-2.26), GMCR: 152.90 (-0.16), ILMN: 186.35 (-3.52), WSM: 65.88 (-0.05), NXPI: 73.54 (+0.07), CELG: 106.45 (-0.69), HAIN: 107.68 (-0.16), AGN: 196.00 (-1.40), CNC: 91.72 (-1.84), V: 252.43 (+2.34), CALM: 43.03 (-0.09), JAZZ: 170.80 (-1.57), ALXN: 193.81 (+0.67), LOW: 57.69 (+0.12), ULTA: 121.75 (-0.33), MA: 84.80 (-0.95), AVGO: 85.04 (-2.59), PETM: 72.54 (+0.90)

Quarterly Financial Results and Product Approval - Research Reports on Pacira, PAREXEL, WellPoint, Illumina and St. Jude Medical
PR Newswire - Tue Nov 04, 8:00AM CST
Today, Analysts Review released its research reports regarding Pacira Pharmaceuticals Inc. (NASDAQ: PCRX), PAREXEL International Corporation (NASDAQ: PRXL), WellPoint Inc. (NYSE: WLP), Illumina, Inc. (NASDAQ: ILMN) and St. Jude Medical, Inc. (NYSE: STJ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7670-100free.
PRXL: 53.97 (+0.47), STJ: 64.76 (-1.28), ILMN: 186.35 (-3.52), PCRX: 86.02 (-4.18), WLP: 124.15 (-3.65)

Geron Corporation (GERN) Looks Strong: Stock Up 25.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 7:44AM CST
Geron Corporation (GERN) was a big mover last session, as the company saw its shares surge nearly 26% on the day
MDVN: 112.77 (+7.82), ONCY: 0.70 (+0.08), GERN: 2.33 (-0.07), ILMN: 186.35 (-3.52)

Big Cap 20: Health Care, Tech Stocks Rule The Roost
at Investor's Business Daily - Mon Nov 03, 4:58PM CST
Large-cap stocks often get labeled as boring because of overall sluggish price action, but the latest IBD Big Cap 20 list of leading large-cap growth is far from boring. Recent health care-related names like Alexion Pharmaceuticals (ALXN), Illumina...
LNKD: 223.04 (-1.61), ALXN: 193.81 (+0.67), ILMN: 186.35 (-3.52), REGN: 377.84 (+0.90), CRM: 63.97 (+0.88), CELG: 106.45 (-0.69)

Prosensa Holding N.V. (RNA) Jumps: Stock Moves Up 9.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:39AM CST
Prosensa Holding N.V. (RNA) was a big mover last session, as its shares rose nearly 10% on the day.
MDVN: 112.77 (+7.82), MACK: 8.70 (-0.07), RNA: 12.14 (+0.08), ILMN: 186.35 (-3.52)

Alder Biopharmaceuticals (ALDR) Jumps: Stock Rises 6.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 7:51AM CST
Alder Biopharmaceuticals Inc. (ALDR) was a big mover last session, as its shares rose nearly 7% on the day.
MDVN: 112.77 (+7.82), MACK: 8.70 (-0.07), ALDR: 16.57 (-0.25), ILMN: 186.35 (-3.52)

Oncolytics Biotech (ONCY) Looks Strong: Stock Up 21.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 7:44AM CST
Oncolytics Biotech Inc. (ONCY) was a big mover last session, as the company saw its shares surge nearly 22% on the day
MACK: 8.70 (-0.07), MDVN: 112.77 (+7.82), ONCY: 0.70 (+0.08), ILMN: 186.35 (-3.52)

IBD 50 Caps Impressive 2-Week Rally
at Investor's Business Daily - Fri Oct 31, 5:47PM CDT
The IBD 50 just capped its best two-week performance in more than three years -- a run that's produced a batch of breakouts. The index rallied 9.4% over the past two weeks. That's the best two-week period since July 2011, when the IBD 50 roared...
ODFL: 75.12 (-0.13), AAP: 141.85 (-3.71), AKRX: 36.59 (-1.29), ILMN: 186.35 (-3.52), NXPI: 73.54 (+0.07), CDW: 32.59 (+0.11), CELG: 106.45 (-0.69), BIDU: 236.54 (-0.36), GILD: 106.45 (-0.49), JAZZ: 170.80 (-1.57), FLT: 149.18 (-1.29), FL: 54.50 (+0.03), AAPL: 109.01 (+0.31), AVGO: 85.04 (-2.59)

Affymetrix Beats Q3 Earnings & Revenues; Raises '14 View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 2:30PM CDT
Following the earnings release, shares of Affymetrix Inc. (AFFX) climbed 2.3% to close at $8.30 in the last session.
BIIB: 320.75 (-2.72), ILMN: 186.35 (-3.52), AMAG: 34.95 (+0.83), AFFX: 9.43 (-0.02)

Incyte (INCY) Looks Good: Stock Moves 10.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 8:46AM CDT
Incyte (INCY) was a big mover last session, with shares rising nearly 11% on the day.
MDVN: 112.77 (+7.82), BIIB: 320.75 (-2.72), INCY: 69.32 (+0.92), ILMN: 186.35 (-3.52)

Bristol-Myers Squibb (BMY) Jumps: Stock Moves Up 8.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 8:39AM CDT
Bristol-Myers Squibb Company (BMY) was a big mover last session, as its shares rose nearly 9% on the day.
MDVN: 112.77 (+7.82), MACK: 8.70 (-0.07), ILMN: 186.35 (-3.52), BMY: 58.32 (-0.14)

Novo Nordisk A/S (NVO) Shows Strength: Stock Up 6.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 7:51AM CDT
Novo Nordisk A/S (NVO) was a big mover last session, as its shares rose over 6% on the day.
MDVN: 112.77 (+7.82), MACK: 8.70 (-0.07), NVO: 43.69 (-0.10), ILMN: 186.35 (-3.52)

Qiagen Q3 Earnings, Revenues in Line; Outlook Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:50PM CDT
Qiagen's (QGEN) strategic collaborations, test menu expansions and moderately balanced international expansion will likely drive growth over time.
BIIB: 320.75 (-2.72), HSKA: 15.90 (+0.71), ILMN: 186.35 (-3.52), QGEN: 23.48 (-0.20)

Cara Therapeutics (CARA) Worth Watching: Stock Rises 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:39AM CDT
Cara Therapeutics Inc. (CARA) was a big mover last session, as its shares rose over 6% on the day.
MDVN: 112.77 (+7.82), MACK: 8.70 (-0.07), CARA: 8.66 (+0.05), ILMN: 186.35 (-3.52)

Oncolytics Biotech (ONCY) Looks Good: Stock Soars 26% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:25AM CDT
Oncolytics Biotech (ONCY) was a big mover last session, with shares surging almost 26% on the day.
MDVN: 112.77 (+7.82), BIIB: 320.75 (-2.72), ONCY: 0.70 (+0.08), ILMN: 186.35 (-3.52)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 271

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 338

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 126

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 382

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 445

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 246

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 314

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 155

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Century Communities Celebrates New Home Community Launch

Updated Category News Views 171

Exciting Grand Opening for Willow Glenn Community Century Communities, Inc. (NYSE: CCS), a prominent national homebuilder, is thrilled to announce the upcoming Grand Opening for Willow Glenn, a remarkable new residential community featuring spacious, modern two-story homes. Situated with breathtaking views of Mt. Rainier, this community is designed to elevate the living...

Continue Reading
Universal Health Services Welcomes Darren Lehrich as New VP

Updated Category News Views 161

Universal Health Services Announces New Addition to Leadership Universal Health Services, Inc. (NYSE: UHS), a key player in the healthcare sector, has recently welcomed Darren Lehrich to its leadership team as Vice President of Investor Relations. In his new capacity, Lehrich will report directly to CFO Steve Filton, aiming to enhance investor engagement in this critical...

Continue Reading
Provident Financial Services Achieves Impressive Q3 Earnings Results

Updated Category News Views 62

Recent Earnings Update Provident Financial Services, Inc. (NYSE: PFS) has recently shared its financial results for its third quarter, showcasing a remarkable net earnings figure of $46.4 million, equivalent to $0.36 per share. These encouraging results were shared by CEO Tony Labozzetta during a call with investors. He highlighted the successful integration of the...

Continue Reading
EnviroGold Global Strengthens Board with New Executive Appointment

Updated Category News Views 71

EnviroGold Global Welcomes Jackie Przybylowski to Board EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) is thrilled to announce that Jackie Przybylowski, a distinguished executive in the mining and capital markets sector, has joined its Board of Directors. This pivotal appointment takes effect as the company progresses the rollout of its innovative NVRO...

Continue Reading
Syensqo Reports Strong Q4 and Full Year 2024 Performance

Updated Category News Views 754

Syensqo's Remarkable Fourth Quarter and Full Year 2024 Performance Syensqo recently announced its highlights for the fourth quarter and full year of 2024, showcasing impressive growth in a challenging market landscape. This performance reflects the company's resilience and strategic vision. Quarter Four Achievements During Q4 of 2024, Syensqo achieved net sales of €1.6...

Continue Reading